Development of Healthcare Transition for Patients With Congenital Adrenal Hyperplasia
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trials Related to Neurocrine Biosciences
Related studies linked through entity extraction aliases.
Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia
- Status
- RECRUITING
- Phase
- PHASE2
Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia
- Status
- RECRUITING
- Phase
- PHASE2
An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Status
- RECRUITING
- Phase
- PHASE3
Pharmacokinetics, Safety and Tolerability of Crinecerfont in Participants With Congenital Adrenal Hyperplasia Who Are Less Than 2 Years Old
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Status
- RECRUITING
- Phase
- PHASE3
Valbenazine in Obsessive Compulsive Disorder
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Status
- RECRUITING
- Phase
- PHASE4
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Status
- RECRUITING
- Phase
- PHASE3
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Status
- RECRUITING
- Phase
- PHASE3
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Status
- RECRUITING
- Phase
- PHASE3
Long-term Study to Evaluate Safety and Tolerability of Valbenazine in Participants With Chorea Associated With Huntington Disease in Canada
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of NBI-1070770 in Adults With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE2
Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease
- Status
- COMPLETED
- Phase
- PHASE3